Terms: = Uterine cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
225 results:
1. Protective effect of quercetin on lipopolysaccharide‑induced miscarriage based on animal experiments and network pharmacology.
Wu S; Tian Y; Zhang Q; Fu Z; Lan H; Zhou X; Ma L; Lou Y
Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38606505
[TBL] [Abstract] [Full Text] [Related]
2. Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-erk Signaling Pathway in Endometrial cancer Cells.
Tian S; Ren L; Liu C; Wang Z
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474453
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of PD-L1 in Cervical cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
Bräutigam K; Schmidt T; Baur M; Tauber N; Kontomanolis EN; Hemptenmacher F; Rody A; Köster F
Anticancer Res; 2024 Feb; 44(2):503-510. PubMed ID: 38307554
[TBL] [Abstract] [Full Text] [Related]
4. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/erk MAPK signalling.
Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
[TBL] [Abstract] [Full Text] [Related]
5. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
6. Alkaloids from
Wan Q; Xu J; Zhu C; Liu X; Tu Y; Lei J; Yu J
J Agric Food Chem; 2023 Jul; 71(27):10349-10360. PubMed ID: 37392181
[No Abstract] [Full Text] [Related]
7. E7050 Suppresses the Growth of Multidrug-Resistant Human uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways.
Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
[TBL] [Abstract] [Full Text] [Related]
8. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/erk/TRIB3 pathway.
Zhang W; Liu M; Ji Y; Yu D; Ma C; Zhao J; Qu P
Arch Biochem Biophys; 2023 Jul; 743():109655. PubMed ID: 37285895
[TBL] [Abstract] [Full Text] [Related]
9. Research advances in endometriosis-related signaling pathways: A review.
Zhang M; Xu T; Tong D; Li S; Yu X; Liu B; Jiang L; Liu K
Biomed Pharmacother; 2023 Aug; 164():114909. PubMed ID: 37210898
[TBL] [Abstract] [Full Text] [Related]
10. uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
Bai L; Chen Y; Han L; Zheng A; Mo X
BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
[TBL] [Abstract] [Full Text] [Related]
11. Tumor Necrosis Factor-
Chen X; Lin L; Wu Q; Li S; Wang H; Sun Y
Mediators Inflamm; 2023; 2023():5679966. PubMed ID: 37124061
[TBL] [Abstract] [Full Text] [Related]
12. Long non‑coding RNA BLACAT2/miR‑378a‑3p/YY1 feedback loop promotes the proliferation, migration and invasion of uterine corpus endometrial carcinoma.
Zhang C; Wang R; Li M; Yang Q
Oncol Rep; 2023 May; 49(5):. PubMed ID: 37052291
[TBL] [Abstract] [Full Text] [Related]
13. uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
[TBL] [Abstract] [Full Text] [Related]
14. [Apolipoprotein E enhances migration of endometrial cancer cells byactivating the erk/MMP9 signaling pathway].
Wu C; Cheng W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):232-241. PubMed ID: 36946043
[TBL] [Abstract] [Full Text] [Related]
15. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
16. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
17. Microenvironmental elements singularity synergistically regulate the behavior and chemosensitivity of endometrioid carcinoma.
Morito S; Kawasaki M; Nishiyama M; Sakumoto T; Hashiguchi M; Narita T; Kawaguchi A; Toda S; Aoki S
Hum Cell; 2023 May; 36(3):1147-1159. PubMed ID: 36853404
[TBL] [Abstract] [Full Text] [Related]
18. Adipocyte and Adipokines Promote a uterine Leiomyoma Friendly Microenvironment.
Afrin S; Ramaiyer M; Begum UAM; Borahay MA
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771423
[TBL] [Abstract] [Full Text] [Related]
19. CLEFMA induces intrinsic and extrinsic apoptotic pathways through erk1/2 and p38 signalling in uterine cervical cancer cells.
Lee CY; Hsiao YH; Chen PN; Wu HH; Lu CY; Yang SF; Wang PH
J Cell Mol Med; 2023 Feb; 27(3):446-455. PubMed ID: 36645157
[TBL] [Abstract] [Full Text] [Related]
20. Resveratrol against Cervical cancer: Evidence from In Vitro and In Vivo Studies.
Nadile M; Retsidou MI; Gioti K; Beloukas A; Tsiani E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558430
[TBL] [Abstract] [Full Text] [Related]
[Next]
